GI
ANAC

GLG Inc’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

GLG Inc’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$372K Buy
+22,181
New +$307K 0.01% 628

Other funds holding ANAC

RCP
Rho Capital Partners New York $20.4M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

GLG Inc's ANAC Position: Q4 2013 in Review

GLG Inc opened a new position in ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2013: 22,181 shares worth $372K. The stake represents 0.01% of the portfolio and ranks #628 among its holdings.

87 funds tracked by Wall St. Rank hold ANAC as of Q4 2013.

  • GLG Inc held 22,181 shares of ANACOR PHARMACEUTICALS INC COM worth $372K as of Q4 2013.
  • ANACOR PHARMACEUTICALS INC COM was a new GLG Inc position in Q4 2013.
  • ANACOR PHARMACEUTICALS INC COM made up 0.01% of GLG Inc's portfolio in Q4 2013, its #628 holding.
  • 87 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.